Celldex Therapeutics
CLDX
#4526
Rank
C$2.51 B
Marketcap
$37.59
Share price
-0.63%
Change (1 day)
0.98%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.24

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.36. In 2022 the company made an earnings per share (EPS) of -$3.35 a decrease over its 2021 EPS that were of -$2.30.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.24-3.23%
2022-$3.3545.73%
2021-$2.30-23.36%
2020-$3.00-41.05%
2019-$5.08-76.95%
2018-$22.0645.03%
2017-$15.21-42.54%
2016-$26.47-3.82%
2015-$27.52-0.76%
2014-$27.7329.41%
2013-$21.43-0%
2012-$21.43-9.73%
2011-$23.741312.5%
2010-$1.68-95.79%
2009-$39.88-49.64%
2008-$79.20-82.64%
2007-$456.27-44.98%
2006-$829.361270.83%
2005-$60.5033.33%
2004-$45.38-10%
2003-$50.42-16.67%
2002-$60.50-38.46%
2001-$98.31-4.88%
2000-$103.35-81.66%
1999-$563.41-87.2%
1998-$4,400206.39%
1997-$1,43613.02%
1996-$1,271

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.62 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.19-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.92 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.82-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.60-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.90-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.80-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA